Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5671618 | Clinical Microbiology and Infection | 2017 | 18 Pages |
Abstract
Future therapeutic development of human CAMPs is not likely to be impeded by the spread of MCR-1 plasmid-mediated resistance to polymyxins, at least in E. coli.
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
J. Dobias, L. Poirel, P. Nordmann,